Chemomab Therapeutics Ltd. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KChemomab Therapeutics Ltd.CMMBSep 30

   Foreign issuer report

2. NOTABLES-4Chemomab Therapeutics Ltd.CMMBSep 25

   Merger registration

   Snowdrift Parent Corp, filer

3. NOTABLESCHEDULE 13D/AChemomab Therapeutics Ltd.CMMBSep 9

   Ownership stake disclosure by HBM Healthcare Investments (Cayman) Ltd. (amended)

   HBM Healthcare Investments (Cayman) Ltd., filed by

4. ROUTINE4Chemomab Therapeutics Ltd.CMMBSep 1

   Neil Harris Cohen, insider filing for CMMB

   Neil Harris Cohen, reporting

5. ROUTINE6-KChemomab Therapeutics Ltd.CMMBAug 19

   Foreign issuer report

6. ROUTINESCHEDULE 13GChemomab Therapeutics Ltd.CMMBAug 13

   Ownership stake disclosure by Touchstone Global Investments Pty Ltd

   Touchstone Global Investments Pty Ltd, filed by

7. ROUTINESCHEDULE 13G/AChemomab Therapeutics Ltd.CMMBAug 10

   Ownership stake disclosure by Erik Otto (amended)

   Erik Otto, filed by

8. NOTABLESCHEDULE 13DChemomab Therapeutics Ltd.CMMBJul 16

   Ownership stake disclosure by HBM Healthcare Investments (Cayman) Ltd.

   HBM Healthcare Investments (Cayman) Ltd., filed by

9. ROUTINE6-KChemomab Therapeutics Ltd.CMMBJul 8

   Foreign issuer report

10. ROUTINE3Chemomab Therapeutics Ltd.CMMBJun 3

    Gwen A Melincoff, new insider at CMMB

    Gwen A Melincoff, reporting

11. ROUTINE6-KChemomab Therapeutics Ltd.CMMBJun 2

    Foreign issuer report

12. ROUTINE4Chemomab Therapeutics Ltd.CMMBJun 1

    George Adi Mor, insider filing for CMMB

    George Adi Mor, reporting

13. ROUTINE6-KChemomab Therapeutics Ltd.CMMBMay 14

    Foreign issuer report

14. ROUTINE6-KChemomab Therapeutics Ltd.CMMBMay 6

    Foreign issuer report

15. ROUTINE6-KChemomab Therapeutics Ltd.CMMBApr 28

    Foreign issuer report

16. ROUTINE3Chemomab Therapeutics Ltd.CMMBApr 10

    6 insider filings

    George Adi Mor, new insider at CMMB

    Show all 6

    • 3New insider at CMMBApr 10
    • 3New insider at CMMBApr 10
    • 3New insider at CMMBApr 10
    • 3New insider at CMMBApr 10
    • 3New insider at CMMBApr 10
    • 3New insider at CMMBApr 10

    George Adi Mor, reporting

17. ROUTINE3Chemomab Therapeutics Ltd.CMMBMar 31

    2 insider filings

    Jill M. Quigley, new insider at CMMB

    Show all 2

    • 3New insider at CMMBMar 31
    • 3New insider at CMMBMar 31

    Jill M. Quigley, reporting

18. NOTABLE20-FChemomab Therapeutics Ltd.CMMBMar 23

    Annual report

19. ROUTINE6-KChemomab Therapeutics Ltd.CMMBMar 20

    Foreign issuer report

20. ROUTINE6-KChemomab Therapeutics Ltd.CMMBMar 19

    Foreign issuer report

21. ROUTINESCHEDULE 13G/AChemomab Therapeutics Ltd.CMMBFeb 17

    Ownership stake disclosure by Peter Thiel (amended)

    Peter Thiel, filed by

22. ROUTINESCHEDULE 13G/AChemomab Therapeutics Ltd.CMMBFeb 10

    Ownership stake disclosure by Erik Otto (amended)

    Erik Otto, filed by

23. ROUTINE6-KChemomab Therapeutics Ltd.CMMBNov 21, 2025

    Chemomab Therapeutics Ltd. filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-21

Older filings on EDGAR